|
CLDI Calidi Biotherapeutics Inc 1855485 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-4,160,000.00 |
| Balance Sheet |
|
Current Assets
|
$5,428,000.00 |
|
Assets
|
$7,204,000.00 |
|
Current Liabilities
|
$3,237,000.00 |
|
Liabilities
|
$4,071,000.00 |
|
Equity
|
$3,133,000.00 |
|
Shares Out
|
2082648.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-8,469,000.00 |
|
Investing Cash Flow
|
$-38,000.00 |
| Market Analysis |
Market Cap
|
$2,790,748.32 |
|
Price
|
$1.34 |
|
BVPS
|
1.50 |
|
PB
|
0.89 |
|
EPS
|
-2.94 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:04 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:54 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CLDI documents filed with the SEC.
CLDI Filings
Clear
